Drugs News and Research

RSS

Opinions: Canada's role in global health; Drug licensing agreements promote drug access; Funding for USAID, state; Haiti

After outlining the work of the Global Fund to Fight AIDS, Tuberculosis and Malaria, Michel Kazatchkine, the organization's executive director, highlights the role Canada can play in determining "whether the world can overcome AIDS, tuberculosis and malaria" in a Toronto Star opinion piece, noting the upcoming G8 and G20 summits, as well as the Millennium Development Goal meeting later this year.

23 Jun 2010

Children who experience maltreatment more likely to have frequent headaches as adults, say scientists

Children who experience maltreatment such as emotional, physical and sexual abuse are more likely to experience frequent headaches, including chronic migraine, as adults, say scientists presenting data at the American Headache Society's 52nd Annual Scientific Meeting in Los Angeles this week.

23 Jun 2010

TheraQuest launches new analgesic product pipeline

TheraQuest Biosciences, Inc., a clinical stage pain management company today unveiled its analgesic product pipeline. TheraQuest also announced the launch of its new corporate website at http://www.theraquestinc.com.

23 Jun 2010

Psychotropic medications associated with pediatric ADRs in Denmark: Researchers

Between 1998 and 2007, psychotropic medications were associated with 429 adverse drug reactions in children under 17 in Denmark. Researchers writing in the open access journal BMC Research Notes found that more than half of these were serious and several were birth defects - suggesting that tighter controls on the prescription of psychotropic medications to pregnant women may be required.

23 Jun 2010

FDA approves Hospira's meropenem for injection, USP (I.V.)

Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has received U.S. Food and Drug Administration (FDA) approval for meropenem for injection, USP (I.V.) 500 mg and 1 g vials. The medication, a carbapenem that belongs to the beta-lactam class of antibiotics, is a generic version of AstraZeneca's Merrem® I.V. Sales of the name-brand product in the United States were approximately $200 million in 2009.

23 Jun 2010

Mobile, supervised drug use units considered cost effective: Report

Drug abuse experts believe Melbourne needs a mobile, supervised drug injecting van. This is mainly due to the geographical spread of drug abusers in the region.

22 Jun 2010

Probactive Biotech, Dalat Nuclear Research Institute enter agreement to co-develop cancer drugs

Probactive Biotech, Inc., a Garden Grove, California-based corporation, has entered into an agreement with Dalat Nuclear Research Institute to co-develop a number of cancer drugs, utilizing combinations of antitumor antibodies and antitumor radioactive compounds. Antitumor antibodies have the ability to take antitumor compounds directly to the tumor sites within the body.

22 Jun 2010

Ensemble Discovery announces name change to Ensemble Therapeutics Corporation

Ensemble Discovery today announced that it will begin operating as Ensemble Therapeutics Corporation to reflect the Company's progress and emerging pipeline by applying its macrocycle drug platform to develop novel therapeutics. The new name, Ensemble Therapeutics, conveys the company's leadership and advancement in developing novel macrocycle drug compounds that are small molecules with expanded therapeutic properties of large molecule biological drugs.

22 Jun 2010

Teens to call upon Congress to fund drug research for rare diseases

Teens from across the United States whose siblings have cystic fibrosis will press their elected officials in Washington, D.C., June 24, to fund drug research and increase access to clinical trials for those with rare diseases.

22 Jun 2010

Michigan State University researchers analyze histiocytic sarcomas

Michigan State University veterinarians are taking part in a two-year, $5.3 million project to analyze five cancers in dogs, research that could offer new insight into canine cancer genes and their potential impact on the human form of the disease.

22 Jun 2010

Veterans with substance use disorders utilize violent means to commit suicide: Study

Veterans with substance use disorders who die by suicide are more likely to use violent means (such as a firearm) rather than nonviolent means (such as a drug overdose), new research suggests.

22 Jun 2010

Studying cells in 3-D could help develop drugs to prevent cancer from spreading: Researchers

Showing movies in 3-D has produced a box-office bonanza in recent months. Could viewing cell behavior in three dimensions lead to important advances in cancer research? A new study led by Johns Hopkins University engineers indicates it may happen. Looking at cells in 3-D, the team members concluded, yields more accurate information that could help develop drugs to prevent cancer's spread.

22 Jun 2010

Study: Complex make-up of cells could lead to new types of medicines

A surprising discovery about the complex make-up of our cells could lead to the development of new types of medicines, a study suggests. Scientists studying interactions between cell proteins - which enable the cells in our bodies to function - have shown that proteins communicate not by a series of simple one-to-one communications, but by a complex network of chemical messages.

22 Jun 2010

Connecticut is first state in U.S to expand coverage for low-income residents under Affordable Care Act

Connecticut is the first state in the nation to permanently add low-income adults to its Medicaid program under the new Affordable Care Act, Health and Human Services Secretary Kathleen Sebelius announced today.

22 Jun 2010

First anniversary of Family Smoking Prevention and Tobacco Control Act

One year ago, President Obama signed the historic Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act). Under the Tobacco Control Act, the U.S. Food and Drug Administration obtained authority to regulate tobacco products, with a special emphasis on preventing their use by children and youth and reducing the impact of tobacco on public health.

22 Jun 2010

OXiGENE reports encouraging data from ZYBRESTAT program at Glaucoma and Retinopathies 2010 conference

OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that the company presented an update on its ZYBRESTAT ophthalmology program, including encouraging preclinical data showing that the company's topical formulation achieved target retina/choroid concentrations with minimal systemic exposure.

22 Jun 2010

Protesters ask U.S. to boost funding for Global Fund, HIV/AIDS programs in Africa

Thousands of protesters in Pretoria, South Africa, Thursday "demand[ed] the U.S. increase its AIDS funding for Africa," the Associated Press reports (Naki, 6/17). The protesters delivered a letter to the consulate saying the U.S. is "cutting funding to the Global Fund to Fight AIDS, Tuberculosis and Malaria," which health advocates believe could lead "other countries to follow suit and reduce funding for the fight against HIV," Agence France-Presse writes (6/17).

22 Jun 2010

Pfizer announces voluntary withdrawal of Mylotarg from U.S. market following FDA request

Pfizer Inc. today announced the voluntary withdrawal from the U.S. market of the drug Mylotarg (gemtuzumab ozogamicin) for patients with acute myeloid leukemia (AML), a bone marrow cancer. The company took the action at the request of the U.S. Food and Drug Administration after results from a recent clinical trial raised new concerns about the product's safety and the drug failed to demonstrate clinical benefit to patients enrolled in trials.

22 Jun 2010

Hunger hormone ghrelin heightens the appeal of high-calorie foods over low-calorie foods: Study

The "hunger" hormone ghrelin, which acts in the brain to stimulate hunger and increase food intake, heightens the appeal of high-calorie foods over low-calorie foods, according to a study that will be presented Tuesday at The Endocrine Society's 92nd Annual Meeting in San Diego.

22 Jun 2010

WHO issues comprehensive recommendations on children's medicines

The WHO on Friday issued "its first-ever guidance on how to use more than 240 essential medicines for children under 13," the Associated Press reports. "The data provide information on use, dosage and side effects of medicines as well as warnings about which children should not take them" and possible complications from interactions from drugs taken together, according to the WHO, the news service reports (6/19).

22 Jun 2010

Drugs News and Research

Opinions: Canada's role in global health; Drug licensing agreements promote drug access; Funding for USAID, state; Haiti

Children who experience maltreatment more likely to have frequent headaches as adults, say scientists

TheraQuest launches new analgesic product pipeline

Psychotropic medications associated with pediatric ADRs in Denmark: Researchers

FDA approves Hospira's meropenem for injection, USP (I.V.)

Mobile, supervised drug use units considered cost effective: Report

Probactive Biotech, Dalat Nuclear Research Institute enter agreement to co-develop cancer drugs

Ensemble Discovery announces name change to Ensemble Therapeutics Corporation

Teens to call upon Congress to fund drug research for rare diseases

Michigan State University researchers analyze histiocytic sarcomas

Veterans with substance use disorders utilize violent means to commit suicide: Study

Studying cells in 3-D could help develop drugs to prevent cancer from spreading: Researchers

Study: Complex make-up of cells could lead to new types of medicines

Connecticut is first state in U.S to expand coverage for low-income residents under Affordable Care Act

First anniversary of Family Smoking Prevention and Tobacco Control Act

OXiGENE reports encouraging data from ZYBRESTAT program at Glaucoma and Retinopathies 2010 conference

Protesters ask U.S. to boost funding for Global Fund, HIV/AIDS programs in Africa

Pfizer announces voluntary withdrawal of Mylotarg from U.S. market following FDA request

Hunger hormone ghrelin heightens the appeal of high-calorie foods over low-calorie foods: Study

WHO issues comprehensive recommendations on children's medicines

Drug Discovery - Second Edition eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News